Dysregulation of the EGFR pathway causes aberrant EGFR signaling, which is associated with the early-stage pathogenesis of respiratory diseases, such as cancer, lung fibrosis, COPD, asthma, and cystic fibrosis [40,41]. Here, EGFR is linked to respiratory system disorder.